Prevalence and disease burden of chronic kidney disease

JC Lv, LX Zhang - Renal fibrosis: mechanisms and therapies, 2019 - Springer
Chronic kidney disease (CKD) has been recognized as a leading public health problem
worldwide. The global estimated prevalence of CKD is 13.4%(11.7–15.1%), and patients …

Worldwide access to treatment for end-stage kidney disease: a systematic review

T Liyanage, T Ninomiya, V Jha, B Neal, HM Patrice… - The Lancet, 2015 - thelancet.com
Background End-stage kidney disease is a leading cause of morbidity and mortality
worldwide. Prevalence of the disease and worldwide use of renal replacement therapy …

Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learning

CC Kuo, CM Chang, KT Liu, WK Lin, HY Chiang… - NPJ digital …, 2019 - nature.com
Prediction of kidney function and chronic kidney disease (CKD) through kidney ultrasound
imaging has long been considered desirable in clinical practice because of its safety …

Maintenance dialysis throughout the world in years 1990 and 2010

B Thomas, S Wulf, B Bikbov, N Perico… - Journal of the …, 2015 - journals.lww.com
Rapidly rising global rates of chronic diseases portend a consequent rise in ESRD. Despite
this, kidney disease is not included in the list of noncommunicable diseases (NCDs) …

Predicting renal failure progression in chronic kidney disease using integrated intelligent fuzzy expert system

J Norouzi, A Yadollahpour… - … methods in medicine, 2016 - Wiley Online Library
Background. Chronic kidney disease (CKD) is a covert disease. Accurate prediction of CKD
progression over time is necessary for reducing its costs and mortality rates. The present …

[HTML][HTML] Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs

PM Chen, TS Lai, PY Chen, CF Lai, SY Yang… - The American journal of …, 2015 - Elsevier
Background Multidisciplinary care is advocated as an effective chronic kidney disease
treatment program in a few, but not all, studies. Our study aimed to evaluate the effect of …

Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception …

HW Chou, HT Chiu, CW Tsai, IW Ting… - Nephrology Dialysis …, 2018 - academic.oup.com
Background Direct comparisons of the effectiveness of allopurinol with that of other urate-
lowering agents in chronic kidney disease (CKD) populations, as well as guideline …

Associations between arsenic in drinking water and the progression of chronic kidney disease: a nationwide study in Taiwan

YY Cheng, NC Huang, YT Chang, JM Sung… - Journal of hazardous …, 2017 - Elsevier
To evaluate the associations between exposure to arsenic in drinking water and the
progression of chronic kidney disease (CKD), we conducted a study in Taiwan. We recruited …

Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan

CW Tsai, IW Ting, HC Yeh, CC Kuo - PLoS One, 2017 - journals.plos.org
Background This study examined the progression of chronic kidney disease (CKD) by using
average annual decline in estimated GFR (eGFR) and its risk factors in a 10-year follow-up …

Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses

CW Tsai, HT Chiu, HC Huang, IW Ting… - Nephrology Dialysis …, 2018 - academic.oup.com
Background Very little is known about longitudinal trajectories of serum uric acid (SUA) over
the course of chronic kidney disease (CKD). We aimed to determine whether longitudinal …